Home  >  Products  >  P2RX4 (purinergic receptor P2X, ligand-gated ion channel, 4) Blocking Peptide (the N terminal of protein) (100ug)
P2RX4 (purinergic receptor P2X, ligand-gated ion channel, 4) Blocking Peptide (the N terminal of protein) (100ug)

P2RX4 (purinergic receptor P2X, ligand-gated ion channel, 4) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-P2RX4 antibody (Catalogue #: ARP35512_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP35512
Size: 100 ug
Weight: 43kDa
Gene: 5025
Format: Lyophilized powder
Target: P2RX4 is the receptor for ATP that acts as a ligand gated ion channel. This receptor is insensitive to the antagonists PPADS and suramin.The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel with high calcium permeability. The main pharmacological distinction between the members of the purinoceptor family is the relative sensitivity to the antagonists suramin and PPADS. The product of this gene has the lowest sensitivity for these antagonists. Multiple alternatively spliced transcript variants have been identified for this gene although their full-length natures have not been determined. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: P2X4; P2X4R
See Full Product Listings >